REG - Haleon PLC - Results of Haleon 2024 Annual General Meeting

HALEONAnnouncement

08/05/2024 17:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240508:nRSH6797Na&default-theme=true

RNS Number : 6797N  Haleon PLC  08 May 2024

 

 

Haleon plc: Results of Haleon 2024 Annual General Meeting

 

8 May 2024: Haleon plc (the "Company") (LSE/NYSE: HLN) announces that the
following resolutions were decided by poll vote at the Company's 2024 Annual
General Meeting ("AGM") which was held today.

 

Resolutions 19, 20, 21, 22 and 23 were passed as special resolutions; all
other resolutions were passed as ordinary resolutions. Full text of the
resolutions is contained in the Company's Notice of AGM, which is available at
www.haleon.com (http://www.haleon.com) .

 

Haleon plc - Poll Results

 

 Resolution                                                                            Votes for      For (% of shares voted)  Votes against  Against (% of shares voted)  Total votes cast (excluding withheld)  % of issued share capital voted(1)  Votes withheld(2)
 1       To receive the Annual Report & Accounts                                       7,919,982,698  99.98                    1,912,695      0.02                         7,921,895,393                          86.75                               27,443,703
 2       To approve the Directors' Remuneration Report                                 7,586,720,188  95.74                    337,969,514    4.26                         7,924,689,702                          86.78                               24,649,536
 3       To declare a final dividend                                                   7,925,111,048  99.98                    1,306,988      0.02                         7,926,418,036                          86.80                               22,921,018
 4       To re-elect Sir Dave Lewis                                                    7,776,694,667  98.12                    148,882,400    1.88                         7,925,577,067                          86.79                               23,760,986
 5       To re-elect Brian McNamara                                                    7,895,750,784  99.62                    29,983,210     0.38                         7,925,733,994                          86.79                               23,604,061
 6       To re-elect Tobias Hestler                                                    7,862,098,220  99.20                    63,569,514     0.80                         7,925,667,734                          86.79                               23,660,869
 7       To re-elect Manvinder Singh (Vindi) Banga                                     7,850,438,949  99.05                    75,078,917     0.95                         7,925,517,866                          86.79                               23,816,186
 8       To re-elect Marie-Anne Aymerich                                               7,875,097,674  99.36                    50,511,000     0.64                         7,925,608,674                          86.79                               23,729,379
 9       To re-elect Tracy Clarke                                                      7,811,967,620  98.57                    113,662,811    1.43                         7,925,630,431                          86.79                               23,707,622
 10      To re-elect Dame Vivienne Cox                                                 7,866,672,212  99.26                    58,970,463     0.74                         7,925,642,675                          86.79                               23,695,377
 11      To re-elect Asmita Dubey                                                      7,900,143,514  99.68                    25,487,188     0.32                         7,925,630,702                          86.79                               23,707,349
 12      To re-elect Deirdre Mahlan                                                    6,982,240,376  88.31                    924,143,645    11.69                        7,906,384,021                          86.58                               42,954,032
 13      To re-elect David Denton                                                      7,889,873,836  99.55                    35,557,933     0.45                         7,925,431,769                          86.78                               23,906,285
 14      To re-elect Bryan Supran                                                      7,890,428,132  99.56                    35,117,662     0.44                         7,925,545,794                          86.79                               23,791,864
 15      To re-appoint KPMG LLP as auditor of the Company                              7,909,270,829  99.79                    16,746,573     0.21                         7,926,017,402                          86.79                               23,320,243
 16      To authorise the Audit & Risk Committee to determine the remuneration of      7,924,013,951  99.98                    1,760,576      0.02                         7,925,774,527                          86.79                               23,561,370
         the auditor
 17      To authorise the Company to make political donations                          7,860,827,630  99.42                    45,956,705     0.58                         7,906,784,335                          86.58                               42,553,903
 18      To authorise the Directors to allot shares                                    7,674,156,770  96.83                    250,966,046    3.17                         7,925,122,816                          86.78                               24,216,236
 19      General authority to disapply pre-emption rights                              7,708,543,512  97.28                    215,438,109    2.72                         7,923,981,621                          86.77                               25,356,460
 20      Additional authority to disapply pre-emption rights                           7,612,018,804  96.06                    311,981,315    3.94                         7,924,000,119                          86.77                               25,336,232
 21      To shorten the notice period for General Meetings                             7,511,133,326  94.77                    414,387,584    5.23                         7,925,520,910                          86.79                               23,816,443
 22      To authorise the Company to purchase its own shares                           7,902,657,875  99.73                    21,458,230     0.27                         7,924,116,105                          86.77                               25,218,017
 23      To authorise the Company to make off-market purchases of its own shares from  5,857,582,236  99.90                    5,872,298      0.10                         5,863,454,534                          64.21                               418,101,609
         Pfizer(3)

 

(1) For the purposes of section 341 of the Companies Act 2006, Haleon plc's
total issued share capital with voting rights as at 6.30pm on Friday 3 May
2024, being the time at which a shareholder had to be registered in the
Company's register of members in order to attend and vote at the AGM, was
9,132,301,104.

(2) A "Vote withheld" is not a vote in law and is not counted in the
calculation of the votes "For" or "Against" a resolution.

(3) Pfizer Inc. did not vote any of the ordinary shares held in respect of
Resolution 23.

 

As required by the Listing Rule 9.6.2R of the Financial Conduct Authority
("FCA"), copies of resolutions passed by the Company other than resolutions
concerning ordinary business have been submitted to the FCA via the National
Storage Mechanism and will shortly be available to the public for inspection
at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

 

Amanda Mellor

Company Secretary

 

 

About Haleon

Haleon (LSE / NYSE: HLN) is a global leader in consumer health, with a purpose
to deliver better everyday health with humanity. Haleon's product portfolio
spans five major categories - Oral Health, Pain Relief, Respiratory Health,
Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its
long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu,
Otrivin, Polident, parodontax and Centrum - are built on trusted science,
innovation and deep human understanding.

 

For more information, please visit www.haleon.com (http://www.haleon.com) .

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGQVLFBZELBBBF